Galena Biopharma
  • Home
  • About Us
  • Technology
    • Cancer Background
    • Cancer Immunotherapy
  • Pipeline
    • NeuVax™ (E75)
    • FBP (E39)
  • Clinical Trials
  • Business Development
  • Investors
    • Stock Information
    • Press Releases
    • Events & Presentations
    • SEC Filings
    • Email Alerts
    • Corporate Governance
  • News
  • Resources
Discovery. Delivery. Development. Technology

Galena Biopharma is focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using targeted biotherapeutics.

Galena Biopharma Company Presentation

Click to View the Latest RXi Pharmaceuticals Comany Presentation

Galena Biopharma in the News

Galena Biopharma Reports First Quarter 2012 Financial Results

Galena Biopharma Announces Expansion of Scientific Advisory Board

Galena Biopharma Notified That RXi Pharmaceuticals' Common Stock to Commence Trading Under Ticker Symbol "RXII"

Galena Biopharma to Present at the Immunotherapy Leaders' Forum 2012

More news
Email Print
  • Home
  • Legal
  • LinkedIn
  • Galena Biopharma. All rights reserved.
info@galenabiopharma.com
1-855-855-GALE
310 N. State Street, Suite 208 | Lake Oswego, OR 97034